Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.


Iran targets US bases in Jordan, the Gulf after Trump orders strikes near Hormuz
12 killed, 9 injured in Johannesburg shooting, South African police say
Anti-immigrant protests flare up across Belfast after knife attack
Pakistani airstrikes kill at least 13 in Afghanistan, Taliban says
Congo says number of confirmed Ebola cases rises to nearly 600
